Validity of the 3-item Patient Health Questionnaire (PHQ-3) for Identifying Moderate-to-Severe Depressive Symptoms Among Elderly Perioperative Patients: A Secondary Analysis of a National Prospective Cohort

September 9, 2026 updated by: Jingsheng Lou, Chinese PLA General Hospital
This is a retrospective observational study based on our hospital's prospective peri-operative elderly patient database. We aim to evaluate the correlation between the 9-item Patient Health Questionnaire (PHQ-9) and the brief 3-item Patient Health Questionnaire (PHQ-3) for screening depressive symptoms among elderly surgical patients. Secondary outcomes include the associations of the two scales with adverse events: 30-day post-operative mortality, readmission, surgical site infection, delirium, and 1-year all-cause mortality. No additional interventions will be performed; only existing routinely-collected clinical data will be analysed.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

10536

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing Municipality
      • Beijing, Beijing Municipality, China, 100853
        • Chinese PLA General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Elderly surgical patients aged 65 years or older who underwent non-neurosurgical and non-cardiac surgery under general anesthesia and were enrolled in our hospital's prospective perioperative database, with complete perioperative PHQ-3 and PHQ-9 assessments

Description

Inclusion Criteria:

  • 1. Aged ≥ 65 years old 2. Patients undergoing surgery under general anesthesia

Exclusion Criteria:

  • 1. ASA physical status ≥ IV (including ASA class IV) 2. Patients transferred to the intensive care unit (ICU) after surgery 3. Preoperative history of schizophrenia, epilepsy, or Parkinson's disease 4. Diseases requiring corticosteroid therapy for more than 7 days within 1 year before surgery 5. Preoperative inability to communicate (coma, severe dementia, or language/hearing impairment), or MMSE score < 26 6. Any cerebrovascular event within the past 3 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
1-year all-cause mortality after surgery
Time Frame: 12 months after surgery
12 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2020

Primary Completion (Actual)

April 30, 2022

Study Completion (Actual)

April 30, 2022

Study Registration Dates

First Submitted

September 9, 2026

First Submitted That Met QC Criteria

September 9, 2026

First Posted (Actual)

September 14, 2026

Study Record Updates

Last Update Posted (Actual)

September 14, 2026

Last Update Submitted That Met QC Criteria

September 9, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 301YXM02

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.